Pharmacotherapy of Polycystic Ovary Syndrome: An Update

    Lekha Saha, Sharonjeet Kaur, Pradip Kumar Saha
    Image of study
    TLDR New treatments for PCOS show promise, but no current medication treats all aspects of the condition.
    The document from 2011 reviews pharmacological treatments for polycystic ovary syndrome (PCOS), including oral contraceptives, antiandrogens, clomiphene, letrozole, gonadotropins, and ovarian drilling for various symptoms and complications of PCOS. Insulin sensitizers like metformin and thiazolidinediones are discussed for improving insulin sensitivity and ovulation rates, but their effectiveness in reproductive outcomes is limited. Newer treatments such as melatonin and N-acetyl cysteine show promise in managing PCOS symptoms. Acarbose is mentioned for its potential benefits in reducing insulin resistance and hyperandrogenism, while statins may improve hyperandrogenemia and cardiovascular risks. Despite the range of treatments, none fully address all aspects of PCOS, indicating a need for ongoing research and development of more effective therapies.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    6 / 1000+ results